Publicaciones (37) Publicaciones de IDOIA GALLEGO GARRIDO

2024

  1. Comparative analysis of lipid-peptide nanoparticles prepared via microfluidics, reverse phase evaporation, and ouzo techniques for efficient plasmid DNA delivery

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 201

  2. Expanding the horizon of transient CAR T therapeutics using virus-free technology

    Biotechnology Advances, Vol. 72

  3. Hydrogel bioink formulation for 3D bioprinting: Sustained delivery of PDGF-BB and VEGF in biomimetic scaffolds for tendon partial rupture repair

    International Journal of Bioprinting, Vol. 10, Núm. 3, pp. 442-467

  4. Potential of injectable psoralen polymeric lipid nanoparticles for cancer therapeutics

    Arabian Journal of Chemistry, Vol. 17, Núm. 10

2023

  1. 3D Bioprinting for Ocular Applications

    3D Printing and Bioprinting for Pharmaceutical and Medical Applications (CRC Press), pp. 221-245

  2. An SPM-Enriched Marine Oil Supplement Shifted Microglia Polarization toward M2, Ameliorating Retinal Degeneration in rd10 Mice

    Antioxidants, Vol. 12, Núm. 1

  3. Assessment of Different Niosome Formulations for Optogenetic Applications: Morphological and Electrophysiological Effects

    Pharmaceutics, Vol. 15, Núm. 7

  4. Erratum: Nanodiamonds Integration into Niosomes as an Emerging and Efficient Gene Therapy Nanoplatform for Central Nervous System Diseases (ACS Appl. Mater. Interfaces (2022) 14:11 (13665−13677) DOI: 10.1021/acsami.2c02182)

    ACS Applied Materials and Interfaces

  5. Lenvatinib-Loaded Poly(lactic-co-glycolic acid) Nanoparticles with Epidermal Growth Factor Receptor Antibody Conjugation as a Preclinical Approach to Therapeutically Improve Thyroid Cancer with Aggressive Behavior

    Biomolecules, Vol. 13, Núm. 11

  6. Long-term biophysical stability of nanodiamonds combined with lipid nanocarriers for non-viral gene delivery to the retina

    International Journal of Pharmaceutics, Vol. 639

  7. Stability of Monoclonal Antibodies as Solid Formulation for Auto-Injectors: A Pilot Study

    Pharmaceutics, Vol. 15, Núm. 8

  8. The role of microfluidics and 3D-bioprinting in the future of exosome therapy

    Trends in Biotechnology, Vol. 41, Núm. 11, pp. 1343-1359

2022

  1. 3D Bioprinted Hydroxyapatite or Graphene Oxide Containing Nanocellulose-Based Scaffolds for Bone Regeneration

    Macromolecular Bioscience, Vol. 22, Núm. 11

  2. Chondroitin and Dermatan Sulfate Bioinks for 3D Bioprinting and Cartilage Regeneration

    Macromolecular Bioscience, Vol. 22, Núm. 3

  3. Design of double functionalized carbon nanotube for amphotericin B and genetic material delivery

    Scientific Reports, Vol. 12, Núm. 1

  4. Nanodiamond Integration into Niosomes as an Emerging and Efficient Gene Therapy Nanoplatform for Central Nervous System Diseases

    ACS Applied Materials and Interfaces, Vol. 14, Núm. 11, pp. 13665-13677

  5. Progress in 3D Bioprinting Technology for Osteochondral Regeneration

    Pharmaceutics, Vol. 14, Núm. 8

  6. Therapeutic Opportunities and Delivery Strategies for Brain Revascularization in Stroke, Neurodegeneration, and Aging

    Pharmacological reviews, Vol. 74, Núm. 2, pp. 439-461

2021

  1. Clay minerals as bioink ingredients for 3d printing and 3d bioprinting: Application in tissue engineering and regenerative medicine

    Pharmaceutics, Vol. 13, Núm. 11

  2. Correlation between biophysical properties of niosomes elaborated with chloroquine and different tensioactives and their transfection efficiency

    Pharmaceutics, Vol. 13, Núm. 11